SEC Form 4 · accession 0001209191-15-019110
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Uy
Officer — EVP & Chief Commercial Officer
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $12.78 | Feb 24, 2015 | A | 80,000 | A | — | Feb 24, 2025 | Common Stock | 80,000 | 207,000 | D |
Explanation of responses
- F112,500 options shall vest on February 24, 2016 and 1,042 options shall vest following each one month period of service after February 24, 2016 for 36 months subject to the reporting person's continued service to the Company through each such vesting date. The remaining options shall vest upon the consummation of a certain strategic transaction.